Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Massimo Mapelli"'
Autor:
Matteo Pagnesi, Riccardo M. Inciardi, Carlo M. Lombardi, Piergiuseppe Agostoni, Pietro Ameri, Lucia Barbieri, Antonio Bellasi, Rita Camporotondo, Claudia Canale, Valentina Carubelli, Stefano Carugo, Francesco Catagnano, Laura A. Dalla Vecchia, Gian Battista Danzi, Mattia Di Pasquale, Margherita Gaudenzi, Stefano Giovinazzo, Massimiliano Gnecchi, Marco Guazzi, Annamaria Iorio, Maria Teresa La Rovere, Sergio Leonardi, Gloria Maccagni, Massimo Mapelli, Davide Margonato, Marco Merlo, Luca Monzo, Andrea Mortara, Vincenzo Nuzzi, Massimo Piepoli, Italo Porto, Andrea Pozzi, Filippo Sarullo, Gianfranco Sinagra, Chiara Tedino, Daniela Tomasoni, Maurizio Volterrani, Gregorio Zaccone, Michele Senni, Marco Metra
Publikováno v:
International Journal of Infectious Diseases, Vol 108, Iss , Pp 270-273 (2021)
Background: Glucocorticoid therapy has emerged as an effective therapeutic option in hospitalized patients with coronavirus disease 2019 (COVID-19). This study aimed to focus on the impact of relevant clinical and laboratory factors on the protective
Externí odkaz:
https://doaj.org/article/6a39914ca2c24770bdb7cae5783c61d8
Autor:
Beatrice Pezzuto, Massimo Piepoli, Arianna Galotta, Susanna Sciomer, Denise Zaffalon, Domenico Filomena, Carlo Vignati, Mauro Contini, Marina Alimento, Nikita Baracchini, Anna Apostolo, Pietro Palermo, Massimo Mapelli, Elisabetta Salvioni, Cosimo Carriere, Marco Merlo, Silvia Papa, Jeness Campodonico, Roberto Badagliacca, Gianfranco Sinagra, Piergiuseppe Agostoni
Background: The role of risk scores in heart failure (HF) management has been highlighted by international guidelines. In contrast with HF, which is intrinsically a dynamic and unstable syndrome, all its prognostic studies have been based on a single
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34931602c75bf07c95d66fc3401c4436
https://hdl.handle.net/11573/1670776
https://hdl.handle.net/11573/1670776
Autor:
Margherita Gaudenzi, Riccardo M. Inciardi, Filippo M. Sarullo, Michele Senni, Matteo Pagnesi, Carlo Lombardi, Marco Metra, Antonio Bellasi, Francesco Catagnano, Gianfranco Sinagra, Laura Adelaide Dalla Vecchia, Massimiliano Gnecchi, Lucia Barbieri, Daniela Tomasoni, Annamaria Iorio, Gregorio Zaccone, Marco Guazzi, Stefano Giovinazzo, Davide Margonato, Andrea Mortara, Maurizio Volterrani, Mattia Di Pasquale, Massimo F Piepoli, Stefano Carugo, Maria Teresa La Rovere, Marco Merlo, Vincenzo Nuzzi, Andrea Pozzi, Valentina Carubelli, Sergio Leonardi, Piergiuseppe Agostoni, Italo Porto, Rita Camporotondo, Gloria Maccagni, Massimo Mapelli, Luca Monzo, Claudia Canale, Pietro Ameri, Gian Battista Danzi, Chiara Tedino
Publikováno v:
International Journal of Infectious Diseases, Vol 108, Iss, Pp 270-273 (2021)
Background: Glucocorticoid therapy has emerged as an effective therapeutic option in hospitalized patients with coronavirus disease 2019 (COVID-19). This study aimed to focus on the impact of relevant clinical and laboratory factors on the protective